Work

Venetoclax Therapy for Relapsed and Treatment Refractory AML: Clinical Outcomes and Molecular Predictors

Year: 2020

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2020-137815

Authors: Maximilian Stahl, Kamal Menghrajani, Andriy Derkach, Alexander Chan, Wenbin Xiao, Jacob L Glass, Amber C. King, Anthony Daniyan, Christopher Famulare, Bernadette M. Cuello, Omar Abdel-Wahab, Ross L. Levine, Aaron D Viny, Eytan M. Stein, Mikhail Roshal, Martin S. Tallman, Aaron D Goldberg

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3095860249

FWCI: 0.136

Cites:

Cited by: 1

Related to: 10